Clinical Trial

Effects of Esketamine Combined With Dexmedetomidine on Postoperative Sleep Quality

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 5, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
1. Eligible patients are randomly divided into experimental and control groups； 2. The experimental group is given esketamine combined with dexmedetomidine，while the control group is given normal saline； 3. The patients' sleep, pain, and cognition are followed up after surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-25.
Trial Details
NCT Number NCT07002723
Lead Sponsor Peking University Shenzhen Hospital
Conditions Hip Fractures
Enrollment 96 participants
Start Date 2025-06-20
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-05